Canada markets closed

Bellerophon Therapeutics, Inc. (BLPH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05510.0000 (0.00%)
At close: 11:08AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
15,808
16,362
13,015
17,890
Selling General and Administrative
5,764
6,022
7,146
8,386
Total Operating Expenses
21,572
22,384
20,161
26,276
Operating Income or Loss
-21,572
-22,384
-20,161
-26,276
Interest Expense
-
-
-
250
Total Other Income/Expenses Net
-
1
600
-327
Income Before Tax
-21,504
-22,248
-19,556
-26,853
Income Tax Expense
-2,417
-2,417
-1,800
-2,125
Income from Continuing Operations
-19,087
-19,831
-17,756
-24,728
Net Income
-19,087
-19,831
-17,756
-24,728
Net Income available to common shareholders
-19,087
-19,831
-17,756
-24,728
Basic EPS
-0.89
-2.08
-1.87
-3.17
Diluted EPS
-0.89
-2.08
-1.87
-3.17
Basic Average Shares
11,103
9,551
9,503
7,797
Diluted Average Shares
11,103
9,551
9,503
7,797